RESMED Earnings, adjusted for pretax expenses and costs related to mergers and acquisitions, were $1 per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 78 cents per share.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$41.25 |
Change
0.120(0.29%) |
Mkt cap ! $23.89B | |||
| Open | High | Low | Value | Volume |
| $41.47 | $41.47 | $41.23 | $34.47M | 834.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89 | $41.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $41.50 | 1500 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| RMD (ASX) Chart |